StockData
MeiraGTx Holdings plc logo

MeiraGTx Holdings plc (MGTX) stock

MGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/3065% below fair value
$7.98−0.16 (-1.97%)

Close on Nov 20, 2026Market cap $766.42MP/E 11.2Yield –

MeiraGTx free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

MeiraGTx's free cash flow for the twelve months ending Jun 30, 2026 was $10.47M. For fiscal 2025 it was -$50.19M. The highest annual figure on record is $11.06M in fiscal 2019.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$50.19M–
FY2024Dec 31, 2024-$109.45M–
FY2023Dec 31, 2023-$125.54M–
FY2022Dec 31, 2022-$118.06M–
FY2021Dec 31, 2021-$56.88M–
FY2020Dec 31, 2020-$84.89M-867.2%
FY2019Dec 31, 2019$11.06M–
FY2018Dec 31, 2018-$70.15M–
FY2017Dec 31, 2017-$28.59M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$38.87M–
Q1 FY2026Mar 31, 2026$15.80M–
Q4 FY2025Dec 31, 2025$46.36M–
Q3 FY2025Sep 30, 2025-$12.83M–
Q2 FY2025Jun 30, 2025-$45.18M–
Q1 FY2025Mar 31, 2025-$38.54M–
Q4 FY2024Dec 31, 2024-$24.49M–
Q3 FY2024Sep 30, 2024-$25.75M–
Q2 FY2024Jun 30, 2024-$20.79M–
Q1 FY2024Mar 31, 2024-$38.42M–
Q4 FY2023Dec 31, 2023-$17.58M–
Q3 FY2023Sep 30, 2023-$27.98M–
Q2 FY2023Jun 30, 2023-$33.99M–
Q1 FY2023Mar 31, 2023-$46.00M–
Q4 FY2022Dec 31, 2022-$24.76M–
Q3 FY2022Sep 30, 2022-$30.74M–
Q2 FY2022Jun 30, 2022-$41.81M–
Q1 FY2022Mar 31, 2022-$20.76M-552.8%
Q4 FY2021Dec 31, 2021-$5.54M–
Q3 FY2021Sep 30, 2021-$29.09M–
Q2 FY2021Jun 30, 2021-$26.84M–
Q1 FY2021Mar 31, 2021$4.58M–
Q4 FY2020Dec 31, 2020-$37.58M–
Q3 FY2020Sep 30, 2020-$15.10M–
Q2 FY2020Jun 30, 2020-$15.80M–
Q1 FY2020Mar 31, 2020-$16.42M-120.3%
Q4 FY2019Dec 31, 2019-$26.72M–
Q3 FY2019Sep 30, 2019-$20.43M–
Q2 FY2019Jun 30, 2019-$22.84M–
Q1 FY2019Mar 31, 2019$81.05M–
Q4 FY2018Dec 31, 2018-$20.35M–
Q3 FY2018Sep 30, 2018-$12.05M–
Q2 FY2018Jun 30, 2018-$19.14M–
Q1 FY2018Mar 31, 2018-$18.61M–
Q4 FY2017Dec 31, 2017-$5.86M–
Q3 FY2017Sep 30, 2017-$7.38M–

More MeiraGTx figures

See a number that looks wrong?